Hologic Acquires Gen-Probe in $3.7B Cash Deal

Matthew Skoufalos | | Radiology Business | Business Intelligence
In a massive cash deal announced today, imaging device maker Hologic will acquire the assets of molecular diagnostics manufacturer Gen-Probe for about $3.7 billion. The deal is expected to close by year’s end 2012. The combined company will operate in 150 countries. From a technological perspective, the deal centers on the Gen-Probe TIGRIS and PANTHER instruments, APTIMA-branded assays, which will supplement the Hologic portfolio of diagnostic imaging equipment for women’s health. Within three years, Hologic believes operations at the two companies could be consolidated to save around $75 million in costs while generating enough liquidity to lower their debts to pre-merger levels.

Matthew Skoufalos

Related Content

Mexico, not China, is biggest tariff concern among radiology vendors
DirectMed Imaging acquires Richardson Healthcare
Medical imaging trends to watch in 2025
Concerns about private equity's growing influence in radiology
Orano Med breaks ground on $265M thorium production site
Image-interpretation market scoreboard: Radiologists 72%, others 28%

Around the web

Health Imaging
American College of Radiology announces significant expansion of Lung Cancer Screening Registry

The ACR hopes these changes, including the addition of diagnostic performance feedback, will help reduce the number of patients with incidental nodules lost to follow-up each year.

Health Imaging
AI reduces CT lung cancer screening workload by nearly 80%

And it can do so with almost 100% accuracy as a first reader, according to a new large-scale analysis.

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.